Teleflex announced today that the FDA expanded the indication for its QuikClot Control+ device. The expanded indication for the hemostatic device includes mild and moderate bleeding in cardiac surgical procedures. It also includes bone surface bleeding following a sternotomy. Indication expansion allows clinicians to use QuikClot Control+ to control all bleeding in cardiac surgical procedures. […]
Wound Care
Integra Lifesciences expects to resume manufacturing in Boston
Integra LifeSciences (NASDAQ: IART) recently announced that it plans to resume manufacturing in its Boston facility by the end of the fourth quarter. Just two months before, Integra voluntarily recalled all tissue-related products made in Boston and distributed between March 1, 2018 and May 22, 2023. The recalled products included SurgiMend, PriMatrix, Revize and TissueMend. […]
Coloplast to acquire wound care company Kerecis for $1.3B
Coloplast announced today that it entered into an agreement to sign Kerecis, a developer of biologics for the wound care market. The agreement has a total value reaching up to $1.3 billion. Of that, Coloplast intends to pay $1.2 billion in an upfront cash payment. Denmark-based Coloplast sees Kerecis as an “attractive opportunity” to strengthen […]
Sanuwave appoints new CEO
Sanuwave recently announced it appointed Morgan Frank as chief executive officer, effective immediately. Frank has served 19 years as founder and principal of Manchester Management, Sanuwave’s largest outside shareholder, and has served as chair of the Sanuwave board of directors since August 2022. Former CEO Kevin Richardson will remain on the board of directors of […]
Bioventus completes wound business divestiture
Bioventus (Nasdaq:BVS) announced today that it successfully completed the divestiture of its wound business to LifeNet Health. Earlier this month, the Durham, North Carolina-based company announced an agreement to divest the business to LifeNet. The sale includes Bioventus’ skin substitutes, TheraSkin and TheraGenesis. The transaction includes a total cash consideration of $85 million. That features […]
Bioventus divests wound business to LifeNet Health
Bioventus (Nasdaq:BVS) announced today that it signed a definitive agreement to sell its wound business to LifeNet Health. Durham, North Carolina-based Bioventus’ sale includes its skin substitutes, TheraSkin and TheraGenesis. The transaction includes a total cash consideration of $85 million. That features $35 million at close, $5 million deferred 18 months and $45 million in […]
FDA clears Veraflo therapy dressings from 3M
3M (NYSE:MMM) announced today that it received FDA clearances for its Veraflo therapy with two different dressings. The clearances cover the Veraflo Cleanse Choice Complete dressing and V.A.C. Veraflo Cleanse Choice dressing. 3M said they received the first-ever FDA clearance for hydromechanical removal of infectious materials, non-viable tissue and wound debris. This reduces the number […]
Integra LifeSciences stock takes a hit despite Street-beating Q1
Integra LifeSciences shares dipped today despite first-quarter results that beat the consensus revenue forecast. Shares of IART slid 8.5% to $53.84 apiece as the market opened today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell 1.4%. BTIG analyst Ryan Zimmerman said an implied set-up for the […]
Candela launches radiofrequency microneedle system
Candela announced today that it launched its new Profound Matrix system for radiofrequency-delivered skin treatments. Marlborough, Massachusetts-based Candela designed the Profound Matrix system to correct, maintain and restore skin. The multi-application system utilizes the Sublime, Sublative RF and new Matrix Pro applicators. Sublime and Sublative RF deliver bipolar radiofrequency (RF) treatments that improve the appearance […]
MiMedx appoints Joseph Capper as CEO
MiMedx (Nasdaq:MDXG) today announced it appointed Joseph Capper as CEO and director, effective immediately. He replaces interim CEO Todd Newton, who was appointed in September 2022. Newton will remain in his role on the Board of Directors at the Marietta, Georgia–based advanced wound care and therapeutic biologics company. Capper has nearly 30 years of medtech and […]
Integra Lifesciences’ CFO is leaving for the soup business
Integra Lifesciences CFO Carrie Anderson is leaving to take a job at another New Jersey–based company, but it’s not a medtech business. Campbell Soup Co. announced today that Anderson will become its EVP and CFO, effective Feb. 6. She succeeds Mick Beekhuizen, who became president of the Camden, New Jersey–based company’s Meals & Beverages division […]